Theratope STn-KLH therapeutic vaccine data

The company presented early analyses of Canadian data on seven patients treated for breast cancer, 16 with pancreatic cancer and 22 patients with colon cancer, showing tumors can be stabilized for several months. The data were presented at the First International Conference on Engineered Vaccines for Cancer and AIDS in San Francisco.

Five of seven cancer patients in a Phase II trial showed stable disease, with no progression for at least three months. In a previous Phase I trial, 10 of 13 showed no progression. Of seven surviving Phase I patients, three have remained stable for over a year, two having received booster injections of the vaccine, and one has received chemotherapy. ...